Cara Therapeutics | CARA - Ebit

Precio De Mercado
3.63
Cambio Diario
0.11 3.13%
Mensual
-2.94%
Anual
-78.47%
Q1 Expectativa
3.41




Ebit Cambio Fecha
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -13.55M 1.69M 2025-12
Chugai Pharma JPY 169.01B 12.52B 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD 56.04M 63.94M 2025-12
CSL USD 2.64B 116M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
J&J USD 5.11B 2.3B 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Pfizer USD 4.65B 71M 2025-12
RedHill Biopharma USD 2.69M 47.97M 2023-06
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12